nach oben

Journal of Natural Medicines

Erschienen in:

01.04.2006 | Review

Phytochemical and analytical studies of Panax notoginseng (Burk.) F.H. Chen

verfasst von: Chong-Zhi Wang, Eryn McEntee, Sheila Wicks, Ji-An Wu, Chun-Su Yuan

Erschienen in: Journal of Natural Medicines | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Panax notoginseng (Burk.) F.H. Chen is distributed throughout the southwest of China, Burma and Nepal. The root of this plant, called notoginseng or sanchi, has a long history of use as a remedy in Oriental traditional medicine. Modern studies have found that extracts and compounds from notoginseng exert various physiological effects. The active constituents are mainly recognized as saponins. In this review, we summarized the discovery and analysis of chemical constituents in notoginseng. Fifty-six saponins from notoginseng were isolated and elucidated. All of them are dammarane saponins, 35 of which can be classified as belonging to the protopanaxadiols group, and 21 as belonging to the protopanaxatriols group. Evidence from phytochemical studies on notoginseng demonstrated that no oleanane-type saponin, which exists in Asian ginseng (Panax ginseng) and American ginseng (Panax quinquefolius), was found. Other types of compounds such as non-protein amino acids, polyacetylenes, phytosterols, flavonoids, and polysaccharides, many of which have pharmacological activities, were also isolated from notoginseng. Analytical studies on notoginseng were carried out based on botanical and phytochemical advances. In the qualitative studies, identification of the herbal materials and extracts was the main objective. The utilization of high-performance liquid chromatography (HPLC) fingerprint and molecular biological methods made the identification accurate and efficient. Spectral, chromatographic and immunoassay methods were used for the quantitative analysis. HPLC methods are the main authority regarding the determination of saponins and other types of constituents. The chromatographic conditions and detectors employed in the HPLC are discussed.

Alvarez-Maubecin V, Garcia-Hernandez F, Williams JT, Van B, Elisabeth J (2000) Functional coupling between neurons and glia. J Neurosci 20:4091–4098PubMed

Anon (2004) WHO issues guidelines for herbal medicines. Bull World Health Organ 82:238PubMed

Bombardelli E, Bonati A, Gabetta B, Martinelli EM, Mustich G (1976) Gas–liquid chromatographic and mass spectrometric investigation on saponins in Panax ginseng extracts. Fitoterapia 47:99–106

Chan P, Thomas GN, Tomlinson B (2002) Protective effects of trilinolein extracted from Panax notoginseng against cardiovascular disease. Acta Pharmacol Sin 23:1157–1162PubMed

Chan RYK, Chen WF, Dong A, Guo D, Wong MS (2002) Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 87:3691–3695CrossRefPubMed

Chen Y, Sorensen LK (2000) Determination of marker constituents in Radix Glycyrrhizae and Radix Notoginseng by near infrared spectroscopy. Fresenius J Anal Chem 367:491–496CrossRefPubMed

Chen SE, Staba EJ (1978) American ginseng. I. Large scale isolation of ginsenosides from leaves and stems. Lloydia 41:361–366

Chen FD, Wu MC, Wang HE, Hwang JJ, Hong CY, Huang YT, Yen SH, Ou YH (2001) Sensitization of a tumor, but not normal tissue, to the cytotoxic effect of ionizing radiation using Panax notoginseng extract. Am J Chin Med 29:517–524CrossRefPubMed

Chen Y, Zhan E, Chen H, Duan X, Guo Li (2002) Saponins with low sugar chain from the leaves of Panax notoginseng (Burk) F. H. Chen. J Chin Med Mater 25:176–178

10.

Chen Z, Sun Y, Dong T, Zhan H, Cui X (2003) Comparison of amino acid contents in Panax notoginseng from different habitats. J Chin Med Mater 26:86–88

11.

Chi Q, Guo J, Dang Q (1992) Thin layer chromatography and extractive technology of Panax japonicum C.A. Mey. var. major (Burk.) C. Y. Wu et K. M. Feng growing in Qingba Mountain Area. Chin J Chin Mater Med 17:478–480

12.

Chou TQ, Chu JH (1937) The saponins of the Chinese drug, san-ch’i, Aralia bipinnatifida. Chin J Physiol 12:59–66

13.

Chuang WC, Sheu SJ (1994) Determination of ginsenosides in ginseng crude extracts by high-performance liquid chromatography. J Chromatogr A 685:243–251CrossRef

14.

Committee of Chinese Pharmacopoeia (2005) Pharmacopoeia of the People’s Republic of China 2005, vol 1. Chemical Industry Press, Beijing, pp 10–11

15.

Cui XM, Dong TX, Chen ZJ, Wang CL, Zhan HQ (2002) Studies on change of polysaccharides in Panax notoginseng collected at different times and from different regions. Chin Pharm J 37:818–820

16.

Cui XM, Lo CK, Yip KL, Dong TT, Tsim KW (2003) Authentication of Panax notoginseng by 5S-rRNA spacer domain and random amplified polymorphic DNA (RAPD) analysis. Planta Med 69:584–586CrossRefPubMed

17.

Drasar P, Moravcova J (2004) Recent advances in analysis of Chinese medical plants and traditional medicines. J Chromatogr B 812:3–21CrossRef

18.

Fong HH (2002) Integration of herbal medicine into modern medical practices: issues and prospects. Integr Cancer Ther 1:287–293PubMed

19.

Fowler JC, Kijas JM, Thomas MR (1994) Current molecular methods for plant genome identification. Australas Biotechnol 4:153–157PubMed

20.

Fridman E, Pichersky E (2005) Metabolomics, genomics, proteomics, and the identification of enzymes and their substrates and products. Curr Opin Plant Biol 8:242–248CrossRefPubMed

21.

Fukuda N, Tanaka H, Shoyama Y (2000) Formation of monoclonal antibody against a major ginseng component, ginsenoside Rg1 and its characterization. Cytotechnology 34:197–204CrossRef

22.

Fukuda N, Tanaka H, Shoyama Y (2000) Application of ELISA, western blotting and immunoaffinity concentration for survey of ginsenosides in crude drugs of Panax species and traditional Chinese herbal medicines. Analyst 125:1425–1429CrossRefPubMed

23.

Fukuda N, Tanaka H, Shoyama Y (2001) Double staining of ginsenosides by western blotting using anti-ginsenoside Rb1 and Rg1 monoclonal antibodies. Biol Pharm Bull 24:1157–1160CrossRefPubMed

24.

Fushimi H, Komatsu K, Namba T, Isobe M (2000) Genetic heterogeneity of ribosomal RNA gene and matK gene in Panax notoginseng. Planta Med 66:659–661CrossRefPubMed

25.

Fuzzati N (2004) Analysis methods of ginsenosides. J Chromatogr B 812:119–133CrossRef

26.

Gang FY, Zheng GZ (1992) Chemical compounds from Panax notoginseng. Chin Pharm J 27:38–43

27.

Gao H, Wang F, Lien EJ, Trousdale MD (1996) Immunostimulating polysaccharides from Panax notoginseng. Pharm Res 13:1196–1200CrossRefPubMed

28.

Han JA, Hu WY (1996) Influence of Panax notoginseng (PNS) on pathological action of oxygen free radicals in central nervous system damage. Chin Pharmacol Bull 12:487–489

29.

Han BH, Han YN, Sankawa U, Akyama M, Kawashima K (1980) The radio-immunoassay method for ginsenoside Rg1 of Korean ginseng. Saengyak Hakhoechi 11:133–140

30.

He XG (2000) On-line identification of phytochemical constituents in botanical extracts by combined high-performance liquid chromatographic-diode array detection-mass spectrometric techniques. J Chromatogr A 880:203–232CrossRefPubMed

31.

Heim KE, Tagliaferro AR, Bobilya DJ (2002) Flavonoid antioxidants: chemistry, metabolism and structure–activity relationships. J Nutr Biochem 13:572–584CrossRefPubMed

32.

Hiai S, Oura H, Odaka Y, Nakajima T (1975) Colorimetric estimation of ginseng saponins. Planta Med 28:363–369PubMed

33.

Hou LB, Chen ZD, Chen ZL, Xu CY, Yang XX (2000) Identification of proteins from Panax pseudo ginseng var. notoginseng and its confusable varieties by HPCE. Chin Tradit Herbal Drugs 31:859–860

34.

Hsu CT (1956) Panax ginseng var. notoginseng. Jpn J Pharmacol 6:18–28PubMed

35.

Huang XD, Kong L, Li X, Chen XG, Guo M, Zou HF (2004) Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines. J Chromatogr B 812:71–84CrossRef

36.

Jiang KY, Qian ZN (1995) Effects of Panax notoginseng saponins on post hypoxic cell damage of neurons in vitro. Acta Pharmacol Sin 16:399–402

37.

Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T (1983) Chemical studies on crude drugs. I. On the constituents of ginseng radix rubra. 1. Yakugaku Zasshi 103:612–622PubMed

38.

Kite GC, Howes MJ, Leon CJ, Simmonds MS (2003) Liquid chromatography/mass spectrometry of malonyl-ginsenosides in the authentication of ginseng. Rapid Commun Mass Spectrom 17:238–244CrossRefPubMed

39.

Ko SR, Choi KJ, Kim SC, Han KW (1995) Content and composition of saponin compounds of Panax species. Koryo Insam Hakhoechi 19:254–259

40.

Ko SR, Choi KJ, Kim YH (1996) Comparative study on the essential oil components of Panax species. Koryo Insam Hakhoechi 20:42–48

41.

Kobk-Larsen M, Christensen LP, Vach W, Ritskes-Hoitinga J, Brandt K (2005) Inhibitory effects of feeding with carrots or (-)-falcarinol on development of azoxymethane-induced preneoplastic lesions in the rat colon. J Agric Food Chem 53:1823–1827CrossRefPubMed

42.

Komatsu K, Zhu S, Sasaki Y (2004) Systematic pharmacognostical study on Panax drugs and Curcuma drugs—phylogenetic analysis, molecular authentication and quality evaluation. J Tradit Med 21:251–270

43.

Konoshima T (1999) Cancer chemo preventive activities of Panax notoginseng and ginsenoside Rg1. Stud Plant Sci 6:36–42

44.

Kozuga T, Yokota M, Aono S, Ito Y, Kato H (1980) l-N-β-Oxalyl-α,β-diaminopropionic acid. Jpn Kokai Tokyo Koho, JP 55043045 19800326 Showa, 4 pp

45.

Kwan CY (1995) Vascular effects of selected antihypertensive drugs derived from traditional medicinal herbs. Clin Exp Pharmacol Physiol Suppl 22:S297–S299PubMed

46.

Lang AD, Zhang TY, Ali S (1996) GC/MS/DS analysis of fatty acids in Panax notoginseng. J Beijing Normal Univ (Nat Sci) 32:257–259

47.

Lau A-J, Seo B-H, Woo S-O, Koh H-L (2004) High-performance liquid chromatographic method with quantitative comparisons of whole chromatograms of raw and steamed Panax notoginseng. J Chromatogr A 1057:141–149CrossRefPubMed

48.

Li SH, Chu Y (1999) Anti-inflammatory effects of total saponins of Panax notoginseng. Acta Pharmacol Sin 20:551–554

49.

Li W, Fitzloff JF (2001) A validated method for quantitative determination of saponins in notoginseng (Panax notoginseng) using high-performance liquid chromatography with evaporative light-scattering detection. J Pharm Pharmacol 53:1637–1643CrossRefPubMed

50.

Li LX, Wang ZC, Li SQ, Zhao WD, Zhao WJ, Zhang XF, Wei JX (1988) Effects of Panax notoginseng saponins on hemorrhagic shock in rabbits. Acta Pharmacol Sin 9:52–55

51.

Li Q, Ye YH, Xing QY, Yuan HS (1997) Comparative studies on some amino acids of Panax species. Acta Sci Nat Univ Pekin 33:686–690

52.

Li HZ, Teng RW, Yang CR (2001) A novel hexanordammarane glycoside from the roots of Panax notoginseng. Chin Chem Lett 12:59–62

53.

Li L, Rong T, Dou JP, Song FR, Liu ZQ, Liu SY (2005) Detection of saponins in extract of Panax notoginseng by liquid chromatography: electrospray ionization-mass spectrometry. Anal Chim Acta 536:21–28CrossRef

54.

Li L, Zhang JL, Sheng YX, Guo DA, Wang Q, Guo HR (2005) Simultaneous quantification of six major active saponins of Panax notoginseng by high-performance liquid chromatography: UV method. J Pharm Biomed Anal 38:45–51CrossRefPubMed

55.

Liang YZ, Xie P, Chan K (2004) Quality control of herbal medicines. J Chromatogr B 812:53–70CrossRef

56.

Lin Q, Zhao X, Liu P, Chen Z, Lu Y (2002) Studies on lipophilic constituents of Panax notoginseng. Chin Tradit Herbal Drugs 33:490–492

57.

Liu R, Zhang J, Wei J, Yu H (1990) Chemical constituents of Sanqi (Panax notoginseng kernel oil). Chin Tradit Herbal Drugs 21:242–245

58.

Liu KZ, Li JB, Lu HL, Wen JK, Han M (2004) Effects of Astragalus and saponins of Panax notoginseng on MMP-9 in patients with type 2 diabetic macroangiopathy. Chin J Chin Mater Med 29:264–266

59.

Liu XS, Qu HB, Cheng YY (2005) Determination of active components in a natural herb with near infrared spectroscopy based on artificial neural networks. Chem Res Chin Univ 21:36–43

60.

Long YC, Ye YH, Xing QY (1996) Studies on the neuroexcitotoxin β-N-oxalo-l-α,β-diaminopropionic acid and its isomer α-N-oxalo-l-α, β-diaminopropionic acid from the root of Panax species. Int J Pept Protein Res 47:42–46PubMed

61.

Lui JHC, Staba EJ (1980) The ginsenosides of various ginseng plants and selected products. J Nat Prod 43:340–346CrossRef

62.

Luo XJ, Zhou SY, Wang DL, Sun CM, Chen DW, Zhang RH (2002) Optimizing the extraction process for notoginseng saponin by the uniform design. J Shenyang Pharm Univ 19:122–124

63.

Ma LY, Wang CL, Zhang Q, Du LJ, Chen JM, Xiao PG (1998) Effects of Panax notoginseng saponins on blood supply and energy metabolism of brain tissues. Chin Pharmacol Bull 14:27–29

64.

Ma WG, Mizutani M, Malterud KE, Lu SL, Ducrey B, Tahara S (1999) Saponins from the roots of Panax notoginseng. Photochemistry 52:1133–1139CrossRef

65.

Mahady GB, Fong HHS, Farnsworth NR (2001) Botanical dietary supplements: quality, safety and efficacy. Swets, Tokyo, pp. 17–25

66.

Marty A, Llano I (2005) Excitatory effects of GABA in established brain networks. Trends Neurosci 28:284–289CrossRefPubMed

67.

Matsunaga H, Katano M, Yamamoto H, Mori M, Takata K (1989) Studies on the panaxytriol of Panax ginseng C. A. Meyer: isolation, determination and antitumor activity. Chem Pharm Bull 37:1279–1281PubMed

68.

Matsuura H, Kasai R, Tanaka O, Saruwatari YI, Fuwa T, Zhou J (1983) Further studies on dammarane-saponins of Sanchi-Ginseng. Chem Pharm Bull 31:2281–2287

69.

Mehta T, Zarghami NS, Parker AJ, Cusick PK, Haskell BE (1979) Neurotoxicity of orally or intraperitoneally administered l-3-oxalylamino-2-aminopropionic acid in the mouse. Toxicol Appl Pharmacol 48:1–9CrossRefPubMed

70.

Mita A, Shida R, Kasai N, Shoji J (1979) Enhancement and suppression in production of IgM-antibody in mice treated with purified saponins. Biomedicine 31:223–227PubMed

71.

Ngan F, Shaw P, But P, Wang J (1999) Molecular authentication of Panax species. Phytochemistry 50:787–791CrossRefPubMed

72.

Ohtani K, Mizutani K, Hatono S, Kasai R, Sumino R, Shiota T, Ushijima M, Zhou J, Fuwa T, Tanaka O (1987) Sanchinan A, a reticuloendothelial system activating arabinogalactan from Sanchi-Ginseng (roots of Panax notoginseng). Planta Med 53:166–169PubMed

73.

Oleszek WA (2002) Chromatographic determination of plant saponins. J Chromatogr A 967:147–162CrossRefPubMed

74.

Pan HP, Huang L, Zhou Z, Liang G, Hong XJ, Huan ZM (1993) Experimental studies on anti-aging effect of total saponin from stalk and leaf of Sanchi (Panax notoginseng). Chin Tradit Herbal Drugs 24:581–584

75.

Putalun W, Fukuda N, Tanaka H, Shoyama Y (2004) A one-step immunochromatographic assay for detecting ginsenosides Rb1 and Rg1. Anal Bioanal Chem 378:1338–1341CrossRefPubMed

76.

QuIlez J, GarcIa-Lorda P, Salas-Salvado J (2003) Potential uses and benefits of phytosterols in diet: present situation and future directions. Clin Nutr 22:343–351CrossRefPubMed

77.

Sanada S, Shoji J (1978) Comparative studies on the saponins of ginseng and related crude drugs. I. Shoyakugaku Zasshi 32:96–99

78.

Sanada S, Shoji J, Shibata S (1978) Quantitative analysis of ginseng saponins. Yakugaku Zasshi 98:1048–1054PubMed

79.

Savolainen V, Chase MW (2003) A decade of progress in plant molecular phylogenetics. Trends Genet 19:717–724CrossRefPubMed

80.

Sha DX, Zhang ML (2005) Determination of notoginsenoside R1, ginsenoside Rg1 and Rb1 in radix notoginseng and its preparation by HPLC-ELSD. Chin J Chin Mater Med 30:112–115

81.

Shaw PC, But PP (1995) Authentication of Panax species and their adulterants by random-primed polymerase chain reaction. Planta Med 61:466–469PubMed

82.

Shen Y, Fang XL (2004) Panax notoginseng liposomes: physiological compatibility and effects on cardiocerebrovascular diseases study. Chin J Clin Pharmacol 13:269–273

83.

Sherma J (2003) High-performance liquid chromatography/mass spectrometry analysis of botanical medicines and dietary supplements: a review. J AOAC Int 86:873–881PubMed

84.

Shim YH, Park CD, Kim do H, Cho JH, Cho MH, Kim HJ (2005) Identification of Panax species in the herbal medicine preparations using gradient PCR method. Biol Pharm Bull 28:671–676CrossRefPubMed

85.

Shoyama Y (2000) Pharmacognosical study on secondary metabolites. Yakugaku Zasshi 120:749–765PubMed

86.

Sticher O, Soldati F (1979) HPLC separation and quantitative determination of ginsenosides from Panax ginseng, Panax quinquefolium and from ginseng drug preparations. Planta Med 36:30–42PubMed

87.

Tanaka H, Shoyama Y (2004) Development of analytical methods using monoclonal antibodies against natural products. Foods Food Ingredients J Jpn 209:40–51

88.

Tanaka H, Fukuda N, Shoyama Y (1999) Formation of monoclonal antibody against a major ginseng component, ginsenoside Rb1 and its characterization. Cytotechnology 29:115–120CrossRef

89.

Taniyasu S, Tanaka O, Yang TR, Zhou J (1982) Dammarane saponins of flower buds of Panax notoginseng (Sanchi-Ginseng). Planta Med 44:124–125

90.

Thompson R (2005) A practical guide to HPLC enantioseparations for pharmaceutical compounds. J Liq Chromatogr Relat Technol 28:1215–1231

91.

Uvarova NI, Makhan’kova VV, Malinovskaya GV, Samoshina NF, Atopkina LN, Likhatskaya GN, Kim NY, Anisimov MM, Elyakov GB (2000) Triterpene glycosides from wild and cultivated ginseng occurring in maritime territory: chemical characterization, comparative quantitative analysis, and biological activity study. Pharm Chem J 34:122–129

92.

Voller A, Bartlett A, Bidwell DE (1978) Enzyme immunoassays with special reference to ELISA techniques. J Clin Pathol 31:507–520PubMed

93.

Wan JB, Li SP, Kan KW, Kong LY, Wang YT (2004) Analysis of saponins from Panax notoginseng using pressurized solvent extraction coupled with high performance thin layer chromatography. Chin Nat Med 2:215–218

94.

Wang Y, Bi KS (2003) Fingerprint construction of Panax notoginseng. Chin J Chin Mater Med 28:316–320

95.

Wang JF, Li ZR, Wei JX (1982) Quantitative determination of saponins in the roots of Panax notoginseng, P. ginseng and P. quinquefolius. Chin Pharm J 17:244–245

96.

Wang M, Fan YG, Gao WF (2000) Quantitative determination of notoginsenoside R1 and ginsenoside Rg1, Rb1 in Panax notoginseng and Xuesaitong injection by HPLC gradient elution method. Chin J Pharm Anal 20:410–413

97.

Wang H, Wu XJ, Cui YY, Zhu L, Lu Y, Chen HZ (2005) Up-regulation of M1 muscarinic receptors expressed in CHOm1 cells by panaxynol via cAMP pathway. Neurosci Lett 383:121–126CrossRefPubMed

98.

Wei J, Du Y (1992) Study and development of Sanchi (Panax notoginseng (Burk.) F. H. Chen). Nat Prod Res Dev 4:94–100

99.

Wei JX, Wang JF (1987) Studies on the flavonoids from the leaves of Panax notoginseng (Burk.) F. H. Chen. Bull Chin Mater Med 12:671–673

100.

Wei JX, Wang JF, Chang LY, Du YC (1980) Chemical studies of San-Chi Panax notoginseng (Burk.) F. H. Chen. I. Studies on the constituents of San-Chi root hairs. Acta Pharm Sin 15:359–364

101.

Wei JX, Wang LA, Du H, Li R (1985) Isolation and identification of sanchinoside B1 and B2 from rootlets of Panax notoginseng (Burk.) F. H. Chen. Acta Pharm Sin 20:288–293

102.

Wei J, Chen Y, Cao S (1992) Saponins in the fruit pedicels of Panax notoginseng (Burk.) F.H. Chen. China J Chin Mater Med 17:611–613, 639–640

103.

Wen J, Zimmer EA (1996) Phylogeny and biogeography of Panax L. (the ginseng genus, araliaceae): inferences from ITS sequences of nuclear ribosomal DNA. Mol Phylogenet Evol 6:167–177CrossRefPubMed

104.

White CM, Fan C, Song J, Tsikouris JP, Chow M (2001) An evaluation of the haemostatic effects of hydrophilic, alcohol, and lipophilic extracts of notoginseng. Pharmacotherapy 21:773–777CrossRefPubMed

105.

Willis FM, Felton MJ (2004) UV detectors. Today’s Chem Work 7:49–50

106.

Wu MZ (1979) Studies on the saponin components of plants in Yunnan. IV. Two saponins of Panax notoginseng. Acta Bot Yunnanica 1:119–124

107.

Wu YJ, Zhu XY, Sha XY, Fang XL (2005) The pharmacokinetics and pharmacodynamics of intranasal preparation of Panax notoginseng saponins. Acta Pharm Sin 40:377–381

108.

Xiao SY, Luo GA, Wang YM, Yang XD, Liang QL (2004) Identification of Panax notoginseng and its preparations by LC/MS. Acta Pharm Sin 39:127–131

109.

Xie PS, Yan YZ (1987) HPTLC fingerprint identification of commercial ginseng drugs: reinvestigation of HPTLC of ginsenosides. J High Resolut Chromatogr Chromatogr Commun 10:607–613CrossRef

110.

Yamaguchi H, Kasai R, Matsuura H, Tanaka O, Fuwa T (1988) High-performance liquid chromatographic analysis of acidic saponins of ginseng and related plants. Chem Pharm Bull 36:3468–3473PubMed

111.

Yang F, Du Y (2002) Synthesis of oligosaccharide derivatives related to those from sanqi, a Chinese herbal medicine from Panax notoginseng. Carbohydr Res 337:485–491CrossRefPubMed

112.

Yang TR, Kasai R, Zhou J, Tanaka O (1983) Dammarane saponins of leaves and seeds of Panax notoginseng. Phytochemistry 22:1473–1478CrossRef

113.

Yang C, Wang G, Wu M, Zhou J (1985) Dammarane saponins of the rhizome of Panax notoginseng. Chin Pharm J 20:337–338

114.

Yang NL, Qu HB, Cheng YY (2002) Rapid quantification of total saponins of Panax notoginseng by near infrared spectroscopy. J Zhejiang Univ (Eng Sci) 36:463–466

115.

Yang NL, Cheng YY, Wu YJ (2003) A new method for fast and nondestructive analysis of saponins in Panax notoginseng herb by near infrared spectroscopy. Acta Chimi Sin 61:393–398

116.

Yang NL, Wu YJ, Cheng YY (2003) Simultaneous determination of notoginsenoside R1, ginsenoside Rg1, Rb1 and Rd in Panax notoginseng herb using reversed-phase high performance liquid chromatography. Chin J Anal Chem 31:731–734

117.

Yoshikawa M (2002) Physiological functions of Panax notoginseng. Shokuhin Kagaku 44:35–38

118.

Yoshikawa M, Murakami T, Ueno T, Yashiro K, Hirokawa N, Murakami N, Yamahara J, Matsuda H, Saijoh R, Tanaka O (1997) Bioactive saponins and glycosides. VIII. Notoginseng (1): new dammarane-type triterpene oligoglycosides, notoginsenosides-A, -B, -C, and -D, from the dried root of Panax notoginseng (Burk.) F.H. Chen. Chem Pharm Bull 45:1039–1045PubMed

119.

Yoshikawa M, Murakami T, Ueno T, Hirokawa N, Yashiro K, Murakami N, Yamahara J, Matsuda H, Saijoh R, Tanaka O (1997) Bioactive saponins and glycosides. IX. Notoginseng (2): structures of five new dammarane-type triterpene oligoglycosides, notoginsenosides-E, -G, -H, -I, and -J, and a novel acetylenic fatty acid glycoside, notoginsenic acid β-sophoroside, from the dried root of Panax notoginseng (Burk.) F. H. Chen. Chem Pharm Bull 45:1056–1062

120.

Yoshikawa M, Morikawa T, Yashiro K, Murakami T, Matsuda H (2001) Bioactive saponins and glycosides. XIX. Notoginseng (3): immunological adjuvant activity of notoginsenosides and related saponins: structures of notoginsenosides-L, -M, and -N from the roots of Panax notoginseng (Burk.) F. H. Chen. Chem Pharm Bull 49:1452–1456CrossRefPubMed

121.

Yoshikawa M, Morikawa T, Kashima Y, Ninomiya K, Matsuda H (2003) Structures of new dammarane-type triterpene saponins from the flower buds of Panax notoginseng and hepatoprotective effects of principal ginseng saponins. J Nat Prod 66:922–927CrossRefPubMed

122.

Zhai WM, Yuan YS, Zhou YX, Wei L (2001) HPLC fingerprints identification of Panax ginseng C. A. Mey, P. quinquefolin L. and P. notoginseng (Burk. F. H. Chen). Chin J Chin Mater Med 26:481–482

123.

Zhang GD (1992) Determination of Panax notoginseng and Guanxinning by macroreticular resin-colorimetric method. Chin Tradit Herbal Drugs 12:503–505

124.

Zhang GD, Zhou ZH, Wang MZ, Gao FY (1980) Analysis of ginseng. I. Determination of saponins in Panax ginseng root. Acta Pharm Sin 15:175–181

125.

Zhang LB, Wei JZ, Wu MX (2001) Determination of ginsenoside Rb1, ginsenoside Rb3 and notoginsenoside Fc in essence of tienchi flowers. Chin J Pharm Anal 21:310–312

126.

Zhao P, Liu Y, Yang C (1993) Minor constituents from the roots of Panax notoginseng. Acta Bot Yunnan 15:409–412

127.

Zhao P, Liu YQ, Yang CR (1996) Minor dammarane saponins from Panax notoginseng. Photochemistry 41:1419–1422CrossRef

128.

Zhou J, Huang WG, Wu MZ, Yang CR, Feng GM, Wu ZY (1975) Thiterpenoids from Panax Linn. and their relationship with taxonomy and geographical distribution. Acta Phytotax Sin 13:29–48

129.

http://www.ars-grin.gov/cgi-bin/npgs/html/taxon.pl?402651. Accessed on September 16, 2005

130.

Zhou J, Wu MZ, Taniyasu S, Besso H, Tanaka O, Saruwatari Y, Fuwa T (1981) Dammarane-saponins of Sanchi ginseng, roots of Panax notoginseng (Burk.) F.H. Chen (Araliaceae): structures of new saponins, notoginsenosides-R1 and -R2, and identification of ginsenosides-Rg2 and -Rh1. Chem Pharm Bull 29:2844–2850

131.

Zhou ZH, Zhang GD, Wang JF (1981) Studies on the quantitative analysis of saponins in San Chi, the root of Panax notoginseng (Burk). Acta Pharm Sin 16:535–540

132.

Zhou YC, Zhao HQ, Liang N, Qu Y, Lu XY, Zhang FM (2003) Determination of the contents of ginsenoside Rg1, Re, Rb1 and the notoginsenoside R1 in the total notoginsenosides of the Panax notoginseng (Burk.) F. H. Chen by HPLC. J Shenyang Pharm Univ 20:27–31

133.

Zhu S, Fushimi H, Cai S, Komatsu K (2004) Species identification from Ginseng drugs by multiplex amplification refractory mutation system (MARMS). Planta Med 70:189–192CrossRefPubMed

134.

Zhu Y, Pettolino F, Mau SL, Bacic A (2005) Characterization of cell wall polysaccharides from the medicinal plant Panax notoginseng. Phytochemistry 66:1067–1076CrossRefPubMed

Titel: Phytochemical and analytical studies of Panax notoginseng (Burk.) F.H. Chen
verfasst von: Chong-Zhi Wang
Eryn McEntee
Sheila Wicks
Ji-An Wu
Chun-Su Yuan
Publikationsdatum: 01.04.2006
Verlag: Springer-Verlag
Erschienen in: Journal of Natural Medicines / Ausgabe 2/2006
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI: https://doi.org/10.1007/s11418-005-0027-x

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2006

Analysis of crude drugs using reversed-phase TLC/scanning densitometry. (II) Identification of ginseng, red ginseng, gentian, Japanese gentian, pueraria root, gardenia fruit, schisandra fruit and ginger

Effects of triterpene compounds on cytotoxicity, apoptosis, and immune response in cultured cells

Effects of Eucommia ulmoides Oliver leaf extract on 3T3-L1 differentiation into adipocytes

DNA authentication of So-jutsu (Atractylodes lancea rhizome) and Byaku-jutsu (Atractylodes rhizome) obtained in the market based on the nucleotide sequence of the 18S–5.8S rDNA internal transcribed spacer region

Neurotoxicity and pharmacology of Lathyrus sativus extracts of high- and low-toxicity strains

A quinic acid ester from Strychnos lucida